Early November, Servier China and Alibaba Health signed a new partnership during the 3rd China International Import and Export Expo to optimize digital applications for patients.
Building on their previous cooperation, based on proven expertise in digital healthcare, and in combination with their respective business advantages, Servier and Alibaba Health will further explore patient-centric and technology-driven strategic cooperation that could establish innovative and integrated pharmaceutical healthcare services to provide overall solutions for the patient journey: disease awareness, diagnosis, treatment, prescription, purchase…
“Meeting the evolving therapeutic needs with sights into diseases and patients, Servier China has decided to join a virtuous circle by covering, thanks to digital platforms, the entire patient journey” says Stephane Mascarau, General Manager of Servier China. As Alibaba Health’s long-term partner, we will deepen cooperation with a focus on the exploration of online chronic disease management.”Stephane Mascarau, General Manager of Servier China
In the short time, the partnership will aim at:
And in the following 3 years, both parties will continue to optimize processes and form an effective and standardized cooperation model to replicate online education and treatment programs in the field of chronic diseases to benefit more patients in more disease areas.
About Alibaba Health
Alibaba Health is the flagship platform of Alibaba Group in the field of health. Its mission is to “make health accessible”. Its vision is to “enable big data to power healthcare, change health with the Internet and innovation, and provide one billion people with fair, inclusive, affordable and reliable medical and health services”.
After awarding Servier China with the prestigious “Golden Code Award”, Alibaba Health presented the subsidiary the “Golden Deer” 2020 Most Influential Brand Award in September, recognizing its continuous innovation and exploration in the field of digital healthcare.